These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland. Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952 [TBL] [Abstract][Full Text] [Related]
7. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238 [TBL] [Abstract][Full Text] [Related]
8. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Zawilska JB; Niewiadomski P; Nowak JZ Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071 [TBL] [Abstract][Full Text] [Related]
9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
10. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889 [TBL] [Abstract][Full Text] [Related]
11. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain. Hu Z; Lelievre V; Chao A; Zhou X; Waschek JA Endocrinology; 2000 Feb; 141(2):657-65. PubMed ID: 10650947 [TBL] [Abstract][Full Text] [Related]
12. Multiple signal pathways coupling VIP and PACAP receptors to calcium channels in hamster submandibular ganglion neurons. Kamaishi H; Endoh T; Suzuki T Auton Neurosci; 2004 Mar; 111(1):15-26. PubMed ID: 15109935 [TBL] [Abstract][Full Text] [Related]
13. Role of VIP and PACAP in islet function. Winzell MS; Ahrén B Peptides; 2007 Sep; 28(9):1805-13. PubMed ID: 17559974 [TBL] [Abstract][Full Text] [Related]
14. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor. Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926 [TBL] [Abstract][Full Text] [Related]
15. Characterization of four receptor cDNAs: PAC1, VPAC1, a novel PAC1 and a partial GHRH in zebrafish. Fradinger EA; Tello JA; Rivier JE; Sherwood NM Mol Cell Endocrinol; 2005 Feb; 231(1-2):49-63. PubMed ID: 15713535 [TBL] [Abstract][Full Text] [Related]
16. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging. Kaneki H; Kurokawa M; Ide H J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543 [TBL] [Abstract][Full Text] [Related]
17. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures. Dejda A; Jozwiak-Bebenista M; Nowak JZ Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170 [TBL] [Abstract][Full Text] [Related]
18. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602 [TBL] [Abstract][Full Text] [Related]
19. Structural determinants of natriuretic peptide receptor specificity and degeneracy. He XL; Dukkipati A; Garcia KC J Mol Biol; 2006 Aug; 361(4):698-714. PubMed ID: 16870210 [TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells. Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]